No Data
No Data
No Data
No Data
No Data
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of
GlobeNewswireApr 17 07:00 ET
Express News | HC Wainwright & Co. Reinstates Neutral on First Wave BioPharma
Moomoo 24/7Mar 25 06:44 ET
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
Poster presentations to highlight new quantitative and serologic diagnostic methods for Celiac Disease detection and determination of intestinal mucosal health New tools may serve as companion diagnostics for
GlobeNewswireMar 18 07:00 ET
First Wave BioPharma Is Maintained at Buy by Roth MKM
First Wave BioPharma Is Maintained at Buy by Roth MKM
Dow JonesMar 15 10:00 ET
Express News | Roth MKM Maintains Buy on First Wave BioPharma, Lowers Price Target to $36
Moomoo 24/7Mar 15 09:49 ET
First Wave BioPharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/15/2024 627.27% Roth MKM $40 → $36 Maintains Buy 01/03/2024 708.08% Roth MKM $11 → $40 Maintains Buy 09
BenzingaMar 15 09:47 ET
No Data
No Data